|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Australian Diabetes Screening Study: impaired glucose tolerance and non-insulin-depended显示文摘 | Welbom TA Reid CM Marriott G | 1997 | Diabetes Metab1997，46，17： | 1 |
| 2 | Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance : the Australian Dia- betes, Obesity, and Lifestyle Study ( AusDiab ) 显示文摘 | Barr EL Zimmet PZ Welbom TA | 2007 | Circulation2007，116，： | 1 |
| 3 | Onset of NIDDM occurs at least 4-7 years before clinical diagnosis显示文摘 | Harris MI Klein R Welbom TA | 1992 | Diabetes Care1992，15，： | 1 |
| 4 | Central obesity and multivariable car: diovaseular risk as assessed by the Framingham prediction scores 显示文摘 | Dhaliwal SS Welbom TA | 2009 | Am J Cardiol2009，103，10： | 1 |
| 5 | Induction, recovery, and safety characteristics of sevoflurane in children undergoing ambulatory surgery显示文摘 | Lerman J Davis PJ Welbom LG | 1996 | Anesthesioiogy1996，84，： | 1 |
| 6 | The relationship between visceral ischemia, Proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair 显示文摘 | Welbom MB Oldenburg HS Hess PJ | 2000 | Crit Care Med2000，28，9： | 1 |
| 7 | Comparison of emergence and recovery characteristics of sevoflurane, desflu- rane, and hatothane inpediatric ambulatory patients 显示文摘 | Welbom LG Hannallah RS Norden JM | 1996 | Anesth Analg1996，83，5： | 1 |
| 8 | Virtual Radios 显示文摘 | Vanu Bose Michael Ismert Matt Welbom | 1999 | IEEE Journal on Selected Areas in Communications1999，17，4： | 1 |
| 9 | Comparison of emergence and recovery characteristics of sevoflurane,desflurane,and halothane in pediatric ambulatory patients显示文摘 | Welbom LC Hannallah RS Nortlen JM | 1996 | Anesth Analg1996，83，5： | 1 |
| 10 | Comparison of emergence and recovery characteristic of sevoflurane , desflurane and halothane in pediatric ambulatory patients 显示文摘 | Welbom LG Hannallah RS Norden JM | 1996 | Anesth Analg1996，83，10： | 1 |
| 11 | Onset of NIDDM occurs at least 4 -7 years before clinical diagnosis显示文摘 | Harris MI Klein R Welbom TA | 1992 | Diabetes Care1992，15，： | 1 |
| 12 | Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) 显示文摘 | Barr EL Zimmet PZ Welbom TA | 2007 | Circulation2007，116，： | 1 |
| 13 | Induction, reeovery, and safety eharaeterisries of sevofluane in children undergoing ambulatory surgery: a comparison with halothane 显示文摘 | Lerman J Davis PF Welbom LG | 1996 | Anesthesiology1996，84，6： | 1 |
| 14 | induction,recovery,and safetycharacteristics of sevoflurane in children undergoing ambulatory surgey显示文摘 | Lerman J Davis PJ Welbom LG | | 0，，： | 1 |
| 15 | Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL - 10 and ischemia/reperfusion injury as a new paradigm (reviews) 显示文摘 | Gaines GC Welbom B | 2000 | Shock2000，13，： | 1 |
| 16 | Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis 显示文摘 | Harris MI Klein R Welbom TA | 1992 | Diabetes Care1992，15，7： | 1 |
| 17 | Comparison of emer- gence and recovery characteristics of sevoflurane,desflurane, and halothane in pediatric ambulatory patients显示文摘 | Welbom LG Hannallah RS Norden JM | 1996 | Anesth Analg1996，83，5： | 1 |
| 18 | Induction recovery and safety characteristics of sevoflurane in children undergoing ambula- tory surgey 显示文摘 | Lerman J Davis PJ Welbom LG | 1996 | Anesthesiology1996，84，6： | 1 |
| 19 | Risk of cardiovascular and all-caucse mortality in individuals with diabetes mellitus,impaired fasting glucose,and impaired glucose tolerance:the Australian Diabetes,Obesity,and Lifestyle Study(AusDiab)显示文摘 | Barr EL Zimmet PZ Welbom TA | | 0，，： | 1 |
| 20 | Induction, recovery, and safety characteristics of sevoflurane in children undergoing ambulatory surgery 显示文摘 | Lerman J Davis PJ Welbom LG et al | 1996 | Anesthesiology1996，84，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员